National Bacterial Meningitis Study

Launched by ASSOCIATION CLINIQUE THÉRAPEUTIQUE INFANTILE DU VAL DE MARNE · Dec 7, 2020

Keywords

ClinConnect Summary

The National Bacterial Meningitis Study is a research trial aimed at understanding the types of bacteria that cause bacterial meningitis in children. Bacterial meningitis is a serious illness that can lead to severe health problems or even death. The study will collect information on how often different bacteria are found in children with meningitis, especially since the use of vaccines has changed the patterns of this disease. This information will help doctors make better treatment recommendations.

Children aged from birth to 17 years who show symptoms of meningitis and have a positive test for certain bacteria in their spinal fluid or blood may be eligible to participate. If you join the study, you can expect to have your condition closely monitored, and your data will contribute to a better understanding of bacterial meningitis. This research is important because it can help improve prevention and treatment for this serious condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL).
• • purpura fulminans
• Exclusion Criteria:
• • -